UnitedHealth Group Shares Fall 1.9% as Q1 EPS Seen Down 6.1%
UnitedHealth shares slipped 1.94% to $289.21, lagging the S&P’s 0.94% loss while delivering a 3.27% monthly gain versus the Medical sector’s 2.62% rise. Q1 estimates stand at $6.76 EPS (-6.1% yoy) on $110.26B revenue (+0.6%), full-year EPS $17.70 (+8.3%) on $440.44B (-1.6%) with a 16.7x forward P/E.
1. Share Performance
UnitedHealth Group shares closed at $289.21, down 1.94% from the prior session, underperforming the S&P 500’s 0.94% decline. Over the past month, the stock rose 3.27%, outpacing the Medical sector’s 2.62% gain.
2. Q1 Earnings Projections
Analysts forecast first-quarter EPS of $6.76, a 6.11% decrease year-over-year, on revenue of $110.26 billion, up 0.62% annually. This outlook will be key for investor sentiment ahead of the release.
3. Full-Year Guidance and Valuation
Full-year estimates call for $17.70 EPS (+8.26%) and $440.44 billion in revenue (-1.59%). The stock trades at a forward P/E of 16.67x and PEG of 1.36 versus industry averages of 15.02x and 1.0, respectively.